Abstract P5-13-27: Post-treatment vascularity and vessel shape are associated with survival and response to CDK4/6 inhibitors in hormone receptor-positive metastatic breast cancer (MBC)

MLA

Vidya Sankar Viswanathan, et al. “Abstract P5-13-27: Post-Treatment Vascularity and Vessel Shape Are Associated with Survival and Response to CDK4/6 Inhibitors in Hormone Receptor-Positive Metastatic Breast Cancer (MBC).” Cancer Research, vol. 82, Feb. 2022, pp. P5-13. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........757f590b1c2624368d8c3f9e1d4b5b29&authtype=sso&custid=ns315887.

APA

Vidya Sankar Viswanathan, Nathaniel Braman, Priyanka Reddy, Siddharth Kunte, Jame Abraham, Alberto J Montero, & Anant Madabhushi. (2022). Abstract P5-13-27: Post-treatment vascularity and vessel shape are associated with survival and response to CDK4/6 inhibitors in hormone receptor-positive metastatic breast cancer (MBC). Cancer Research, 82, P5-13.

Chicago

Vidya Sankar Viswanathan, Nathaniel Braman, Priyanka Reddy, Siddharth Kunte, Jame Abraham, Alberto J Montero, and Anant Madabhushi. 2022. “Abstract P5-13-27: Post-Treatment Vascularity and Vessel Shape Are Associated with Survival and Response to CDK4/6 Inhibitors in Hormone Receptor-Positive Metastatic Breast Cancer (MBC).” Cancer Research 82 (February): P5-13. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........757f590b1c2624368d8c3f9e1d4b5b29&authtype=sso&custid=ns315887.